PMC10213914_01
Patient was diagnosed with PSCC. (A) A mass in the left breast. H&E staining results at (B) 10x and (C) x20 objective. (D) Immunohistochemical analysis of GATA.
fphar-14-1115422-g001.jpg
PMC10213914_01_fphar-14-1115422-g001.jpg
F1
It was hard, with poorly defined borders, poor mobility, and no tenderness (Figure 1A). H&E staining showed squamous cell carcinoma (Figures 1B, C). Immunohistochemical results showed GATA (+) (Figure 1D), ER (weak-moderate +, approximately 5%), PR (-), Her-2 (1+), Ki-67 (50%), P63 (+), CK5/6 (+), Mammaglobin (-), and GCDFP_15 (-).
Efficacy of apatinib in this patient. (A) The left breast mass fell off. H&E staining results at (B) 10x and (C) x20 objective.
fphar-14-1115422-g002.jpg
PMC10213914_01_fphar-14-1115422-g002.jpg
F2
TEC (docetaxel/epirubicin/cyclophosphamide) with an efficacy evaluation of stable disease. Therefore, the treatment regimen was changed to 2 cycles of chemotherapy with Apatinib + TEC (docetaxel/epirubicin/cyclophosphamide) with an efficacy evaluation of PR, and one of the patient's approximately 4 cm sublesions fell off (Figure 2A).